The dual orexin receptor antagonist TCS1102 does not affect reinstatement of nicotine-seeking.

PLoS One · 2017 · PMC5351999 · PMID 28296947

Europe PMC DOI

hedged sentence

0.0900

closest p · 1.8× alpha

0.0900

boldest claim

The sentences

a strong trendp = 0.09so close (0.05 < p ≤ 0.1)

Across nicotine-primed reinstatement, there was once again a robust reinstatement of responding as revealed by a main effect of session (F (1,11) = 13.5, p = 0.0037), and a strong trend for session x nosepoke interaction (F (1,11) = 3.45, p = 0.09).

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.